CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving the crystallization process of active pharmaceutical ingredients (APIs) to enhance product quality and safety. By developing a real-time imaging device, manufacturers can monitor and control crystal characteristics during production, leading to better drug formulations.
An active pharmaceutical ingredient (API) is the substance in a pharmaceutical drug that has the pharmacological activity.
The crystallisation process is a critical step in the API manufacturing process and for delivering “product” in its final form, with some 70 % of products going through a crystallization step at some point in their manufacture.
The size and shape of the crystals are important to the quality and safety of the product, and variation during crystal growth can have a significant…
INNOPHARMA LABS LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Finland, OULU
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Spain, CORBERA DE LLOBREGAT
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Ireland, BALLYMOTE SLIGO
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
